PDGFR-beta/VEGF-A antibodies (Zymogenetics/BMS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePDGFR-beta/VEGF-A antibodies (Zymogenetics/BMS)

Drug Alias NameBiscFv-Fc antibodies (Zymogenetics)scFv-based bispecific antibodies (Zymogenetics)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionPlatelet-derived growth factor receptor beta inhibitorsVascular endothelial growth factor A inhibitors

TargetsVascular endothelial growth factor APlatelet-derived growth factor receptor beta

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesZymogenetics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesZymogenetics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A